Abstract:NUT carcinoma is a rare, highly lethal cancer characterized with the rearrangement of the nuclear protein in testis (NUT) gene on chromosome 15q14, which primarily occurs in the midline organs. Primary pulmonary NUT carcinoma (NC) lacks characteristic clinical manifestations, which leads to the high rate of misdiagnose and nonstandard treatment. To date, fewer than one hundred cases have been reported worldwide. Here, a comprehensive literature search involving a total of 35 articles with 55 patients was condu… Show more
“…In terms of epidemiology, primary pulmonary NMC mainly affected children and young adults, with a median age of 29.5 years (range: 6-74 years), younger than in other reports ( 38 , 40 ). Both genders are equally affected.…”
Section: Discussionmentioning
confidence: 63%
“…cases of pulmonary NMC, with the objective of enhancing our understanding of the epidemiological, pathological, and immunohistochemical features of this disease. In terms of epidemiology, primary pulmonary NMC mainly affected children and young adults, with a median age of 29.5 years (range: 6-74 years), younger than in other reports (38,40). Both genders are equally affected.…”
Section: Discussionmentioning
confidence: 75%
“…Given the non-specific histological characteristics of NMC ( 2 , 8 , 28 , 40 , 41 ), most cases expressed p63, p40, CK6/7, EMA, CD99, Vimentin, and AE1/AE3 cytokeratins. In addition to these markers, NMC might also express TTF-1, CD56, Syn, CD30, and CAM5.2, which often leaded to misdiagnosis.…”
Nuclear protein of the testis (NUT) midline carcinoma (NMC) is a rare tumor, with particularly low incidence in the lungs, and a correspondingly poor prognosis. To determine the clinicopathological characteristics, outcomes, and prognostic factors of primary pulmonary NMC, a case was reported and a systematic review was performed. Twenty-nine records, including ours, involving 62 cases, were finally included. The median age at diagnosis was 29.5 years. At presentation, the most common symptoms at presentation were cough (47.50%) and chest/back pain (37.50%). In terms of diagnosis, 32.14% of NMC cases were identified through immunohistochemistry (IHC); However, a greater number of cases may be misdiagnosed initially, and ultimately, the diagnosis of NMC was confirmed through a combination of IHC and fluorescence in situ hybridization (FISH). Despite the clinical application of various chemotherapy-based treatments, the actual effectiveness remains unsatisfactory. Furthermore, Cox regression analysis of multiple factors identified male gender and concurrent presence of pleural effusion as indicators of shorter survival time in patients. These results emphasize the importance of increased diagnostic awareness among clinical and pathology practitioners concerning NMC. While there is currently no established standard for treating NMC, a treatment approach combining multiple methods shows promise for future research. Concurrently, clinical and foundational investigations addressing variables such as gender and the presence of pleural effusion may yield valuable insights into the diagnosis and treatment of NMC.
“…In terms of epidemiology, primary pulmonary NMC mainly affected children and young adults, with a median age of 29.5 years (range: 6-74 years), younger than in other reports ( 38 , 40 ). Both genders are equally affected.…”
Section: Discussionmentioning
confidence: 63%
“…cases of pulmonary NMC, with the objective of enhancing our understanding of the epidemiological, pathological, and immunohistochemical features of this disease. In terms of epidemiology, primary pulmonary NMC mainly affected children and young adults, with a median age of 29.5 years (range: 6-74 years), younger than in other reports (38,40). Both genders are equally affected.…”
Section: Discussionmentioning
confidence: 75%
“…Given the non-specific histological characteristics of NMC ( 2 , 8 , 28 , 40 , 41 ), most cases expressed p63, p40, CK6/7, EMA, CD99, Vimentin, and AE1/AE3 cytokeratins. In addition to these markers, NMC might also express TTF-1, CD56, Syn, CD30, and CAM5.2, which often leaded to misdiagnosis.…”
Nuclear protein of the testis (NUT) midline carcinoma (NMC) is a rare tumor, with particularly low incidence in the lungs, and a correspondingly poor prognosis. To determine the clinicopathological characteristics, outcomes, and prognostic factors of primary pulmonary NMC, a case was reported and a systematic review was performed. Twenty-nine records, including ours, involving 62 cases, were finally included. The median age at diagnosis was 29.5 years. At presentation, the most common symptoms at presentation were cough (47.50%) and chest/back pain (37.50%). In terms of diagnosis, 32.14% of NMC cases were identified through immunohistochemistry (IHC); However, a greater number of cases may be misdiagnosed initially, and ultimately, the diagnosis of NMC was confirmed through a combination of IHC and fluorescence in situ hybridization (FISH). Despite the clinical application of various chemotherapy-based treatments, the actual effectiveness remains unsatisfactory. Furthermore, Cox regression analysis of multiple factors identified male gender and concurrent presence of pleural effusion as indicators of shorter survival time in patients. These results emphasize the importance of increased diagnostic awareness among clinical and pathology practitioners concerning NMC. While there is currently no established standard for treating NMC, a treatment approach combining multiple methods shows promise for future research. Concurrently, clinical and foundational investigations addressing variables such as gender and the presence of pleural effusion may yield valuable insights into the diagnosis and treatment of NMC.
“…Initially, NUT carcinoma was thought to occur more commonly in children and young adults, but recent studies revealed that the tumor could occur at almost any age [28] , with nearly the same incidence in both men and women [25] . And pulmonary NUT carcinoma mainly occurred in young and middle-aged men with no history of smoking (2:1), and the male-to-female ratio was about 1.89 to 1 [29] . He et al.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.